Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 2
2009 3
2010 2
2011 1
2012 2
2014 1
2015 1
2016 2
2019 1
2020 1
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.
Eadon MT, Cavanaugh KL, Orlando LA, Christian D, Chakraborty H, Steen-Burrell KA, Merrill P, Seo J, Hauser D, Singh R, Beasley CM, Fuloria J, Kitzman H, Parker AS, Ramos M, Ong HH, Elwood EN, Lynch SE, Clermont S, Cicali EJ, Starostik P, Pratt VM, Nguyen KA, Rosenman MB, Calman NS, Robinson M, Nadkarni GN, Madden EB, Kucher N, Volpi S, Dexter PR, Skaar TC, Johnson JA, Cooper-DeHoff RM, Horowitz CR; GUARDD-US Investigators. Eadon MT, et al. Among authors: fuloria j. Contemp Clin Trials. 2022 Aug;119:106813. doi: 10.1016/j.cct.2022.106813. Epub 2022 Jun 1. Contemp Clin Trials. 2022. PMID: 35660539 Free PMC article. Clinical Trial.
Increasing Readiness for Early Integrated Palliative Oncology Care: Development and Initial Evaluation of the EMPOWER 2 Intervention.
Perry LM, Sartor O, Malhotra S, Alonzi S, Kim S, Voss HM, Rogers JL, Robinson W, Harris K, Shank J, Morrison DG, Lewson AB, Fuloria J, Miele L, Lewis B, Mossman B, Hoerger M. Perry LM, et al. Among authors: fuloria j. J Pain Symptom Manage. 2021 Nov;62(5):987-996. doi: 10.1016/j.jpainsymman.2021.03.027. Epub 2021 Apr 20. J Pain Symptom Manage. 2021. PMID: 33864847 Free PMC article. Clinical Trial.
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab.
Smith SM, Desai RA, Walsh MG, Nilles EK, Shaw K, Smith M, Chamberlain AM, Derington CG, Bress AP, Chuang CH, Ford DE, Taylor BW, Chandaka S, Patel LP, McClay J, Priest E, Fuloria J, Doshi K, Ahmad FS, Viera AJ, Faulkner M, O'Brien EC, Pletcher MJ, Cooper-DeHoff RM. Smith SM, et al. Among authors: fuloria j. Am Heart J Plus. 2022 Jan;13:100112. doi: 10.1016/j.ahjo.2022.100112. Epub 2022 Mar 2. Am Heart J Plus. 2022. PMID: 35252907 Free PMC article.
Cyclooxygenase 2 inhibitors and colon cancer.
Gonzalez-Angulo AM, Fuloria J, Prakash O. Gonzalez-Angulo AM, et al. Among authors: fuloria j. Ochsner J. 2002 Summer;4(3):176-9. Ochsner J. 2002. PMID: 22822342 Free PMC article. No abstract available.
22 results